Tony Mulone, is currently head of OEM Strategy for Baxter International where he is focused on assessing Baxter’s capabilities to service the B2B market. He also serves as chairman of the board for Signati Medical Inc., a vessel sealing start-up focused on innovating the vasectomy market through bipolar energy. Focused on medical device, Mulone was the general manager for the Custom Product Solutions (CPS) division of Covidien, a 12 billion dollar medical device company. He was responsible for directing the strategic growth into non-hospital markets, which included medical and pharma OEM, animal health, dental, and rehabilitation. The CPS division focused its efforts on providing custom solutions centering its attention on promoting Covidien product brands in these emerging markets. Mulone began his medical device career with Instrumentation Laboratories and then joined Kendall/Tyco Healthcare/Covidien/Medtronic, holding increasing management positions in manufacturing, sales/marketing, and senior leadership as a member of the ELT. He holds a bachelor's degree in economics from Framingham State University (Mass.). He also holds a USGC Masters Captains license.